Trials / Sponsors / Portal Therapeutics, Inc.
Portal Therapeutics, Inc.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria Erythropoietic Protoporphyria (EPP) | Phase 2 | 2025-04-04 |
| Recruiting | Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered Healthy Adult Participants | Phase 1 | 2024-04-08 |